Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
DLC1 Rho GTPase activating protein | 0.529 | 0.731 | 1.00 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2009 | 2009 | ||||||||
|
caudal type homeobox 1 | 0.644 | 0.346 | 0.14 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2008 | 2008 | ||||||||
|
antizyme inhibitor 2 | 0.499 | 0.808 | 8.9E-07 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2019 | 2019 | ||||||||
|
SPO11 initiator of meiotic double stranded breaks | 0.821 | 0.192 | 1.4E-08 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2011 | 2011 | ||||||||
|
LETM1 domain containing 1 | 0.682 | 0.308 | 4.9E-02 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2015 | 2015 | ||||||||
|
glucose-6-phosphate isomerase | 0.491 | 0.769 | 2.8E-06 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 1995 | 1995 | ||||||||
|
C-X-C motif chemokine ligand 17 | 0.647 | 0.615 | 4.8E-03 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2015 | 2015 | ||||||||
|
insulin | 0.445 | 0.923 | 0.30 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 1989 | 1989 | ||||||||
|
serrate, RNA effector molecule | 0.736 | 0.231 | 0.59 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2019 | 2019 | ||||||||
|
dymeclin | 0.563 | 0.769 | 3.6E-13 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2015 | 2015 | ||||||||
|
SWT1 RNA endoribonuclease homolog | 0.839 | 0.115 | 1.00 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2011 | 2011 | ||||||||
|
isoleucyl-tRNA synthetase 2, mitochondrial | 0.590 | 0.654 | 8.1E-02 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2019 | 2019 | ||||||||
|
tribbles pseudokinase 3 | 0.573 | 0.692 | 1.2E-13 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2010 | 2010 | ||||||||
|
suppression of anchorage independence 1 | 0.560 | 0.615 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 1997 | 1997 | |||||||||
|
Ras association domain family member 7 | 0.621 | 0.538 | 2.3E-11 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 1989 | 1989 | ||||||||
|
ubiquitin specific peptidase 9 Y-linked | 0.743 | 0.269 | 5.7E-05 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2000 | 2000 | ||||||||
|
diacylglycerol kinase zeta | 0.656 | 0.538 | 4.0E-02 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2019 | 2019 | ||||||||
|
dynein light chain LC8-type 1 | 0.568 | 0.769 | 0.70 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2009 | 2009 | ||||||||
|
carboxylesterase 2 | 0.584 | 0.731 | 3.6E-16 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 1997 | 1997 | ||||||||
|
spliceosome associated factor 3, U4/U6 recycling protein | 0.584 | 0.769 | 1.00 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2016 | 2016 | ||||||||
|
DLEC1 cilia and flagella associated protein | 0.572 | 0.615 | 2.1E-35 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2009 | 2009 | ||||||||
|
checkpoint kinase 2 | 0.460 | 0.808 | 1.2E-24 |
|
disease | 0.030 | None | 0.333 | 3 | 0 | 2001 | 2018 | ||||||||
|
killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 1 | 0.537 | 0.769 |
|
disease | 0.040 | None | 0.500 | 4 | 0 | 2007 | 2016 | |||||||||
|
Ras association domain family member 1 | 0.420 | 0.808 | 4.9E-06 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2005 | 2014 | ||||||||
|
erb-b2 receptor tyrosine kinase 2 | 0.328 | 0.923 | 6.0E-03 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 1990 | 2009 |